Healthpoint (Luxembourg) II, S.A.R.L., the new majority shareholder of Ideal Medical Products (IMP), announced that Michael D. Huggins will soon join IMP and its subsidiary Scient’x as Chief Executive Officer. Mr. Huggins was previously head of Global Spine at Synthes and has 13 years of experience in the development of innovative products in the spine sector. Mr. Huggins’ formal nomination will take place in the next few weeks.
IMP and Scient’x will continue to benefit from the experience of its current CEO Mr. Olivier Carli. Mr. Carli will remain with the company for the immediate future.
IMP is listed on Compartment C of Eurolist by Euronext Paris (ISIN Code: FR0000053720).
Healthpoint (Luxembourg) II, S.A.R.L. is controlled by HealthpointCapital Partners II, LP, a values-driven, research-based fund exclusively focused on the musculoskeletal sector - specifically orthopedics and dental.
